Results
|
1.
|
Recurrent Gingival Squamous Papilloma: A Rare Finding in a Child. MedStar authors:
Year: 2017
Citation: - Journal of Dentistry for Children (Chicago, Ill.). 84(3):145-148, 2017 Sep 15
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Oral and Maxillofacial Surgery
Medline publication type:
All authors: - Basile JR, Brooks JK, Khoury ZH, Poshni K
|
|
2.
|
|
|
3.
|
|
|
4.
|
PPP6R3-USP6 amplification: Novel oncogenic mechanism in malignant nodular fasciitis. MedStar authors:
Year: 2016
Citation: - Genes, Chromosomes & Cancer. 55(8):640-9, 2016 Aug
Institution: - Medstar Franklin Square Medical Center
Medline publication type:
All authors: - Aboulafia A, Al-Ibraheemi A, Asmann Y, Chou MM, Dong J, Fritchie K, Guo R, Jenkins RB, Jin L, Molavi DW, Oliveira AM, Oliveira JL, Wang X, Wenger DE, Westendorf JJ
|
|
5.
|
Resected WHO grade I meningioma and predictors of local control. MedStar authors:
Year: 2021
Citation: - Journal of Neuro-Oncology. 152(1):145-151, 2021 Mar.
Institution: - MedStar Franklin Square Medical Center
Medline publication type:
All authors: - Andrews DW, Buss E, Casey J, Chitale A, Curtis M, Farrell C, Hegarty SE, Judy K, Kalchman I, Keith SW, Nowak-Choi K, Palmer JD, Shi W, Solomides C, Werner-Wasik M
|
|
6.
|
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. MedStar authors:
Year: 2015
Citation: - Lancet Oncology. 16(9):1037-48, 2015 Sep.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Liu Q, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA
|
|
7.
|
|
|
8.
|
Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005). MedStar authors:
Citation: - Cancer. 119(8):1555-61, 2013 Apr 15.
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Araujo DM, Baker LH, George S, Hensley ML, Maki RG, Priebat DA, Soslow RA, Sutton G, Wathen JK
|
|
9.
|
Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. MedStar authors:
Year: 2019
Citation: - Lancet Oncology. 20(12):1719-1729, 2019 12.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Blay JY, Chawla S, Choy E, Dai T, Gelderblom H, Grimer RJ, Henshaw R, Jandial D, Le Cesne A, Palmerini E, Reichardt P, Rutkowski P, Schuetze SM, Seeger L, Skubitz K
|
|
10.
|
Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients. MedStar authors:
Year: 2018
Citation: - Annals of Surgical Oncology. 25(4):1094-1100, 2018 Apr.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bartlett DL, Glehen O, Goere D, Levine EA, Marolho C, Mercier F, Passot G, PSOGI and BIG RENAPE Groups, Sugarbaker PH, Villeneuve L, Yonemura Y
|
|
11.
|
Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI). MedStar authors:
Year: 2021
Citation: - Oncology. 99(1):41-48, 2021.
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Bijelic L, de Hingh I, Glatzer M, Glehen O, Goere D, Haller L, Li Y, Moran BJ, Morris DL, Piso P, Putora PM, Quadros CA, Rau B, Steffen T, Sugarbaker P, Yonemura Y
|
|
12.
|
|
|
13.
|
Delayed Recurrent and Bilateral Breast Cancer in Patients With Partial Poland's Anomaly: Report of 2 Rare Cases and Review of the Literature. MedStar authors:
- Bozzuto, Laura M
- DeFazio, Michael V
- Dervishaj, Ornela A
Year: 2018
Citation: - Clinical Breast Cancer. 18(3):e285-e290, 2018 06.
Institution: - MedStar Washington Hospital Center
Medline publication type:
All authors: - Bozzuto LM, DeFazio MV, Dervishaj OA, Olding MJ, Pittman TA, Tousimis EA, Willey SC
|
|
14.
|
|
|
15.
|
|
|
16.
|
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5. MedStar authors:
Year: 2017
Citation: - Clinical Breast Cancer. 17(1):48-54.e3, 2017 Feb
Institution: - Washington Cancer Institute
Medline publication type:
All authors: - Ansari B, Buyse ME, Conlin AK, Geyer CE Jr, Gross HM, Jacobs SA, Keogh GP, Lord RS, Mamounas EP, Mauquoi C, Patocskai EJ, Polikoff JA, Rastogi P, Robidoux A, Smith JW 2nd, Stella PJ, Swain SM, Wolmark N
|